Report of the PMDA-ATC Biosimilar Webinar and Pharmacovigilance Webinar for FDA Philippines

On December 14, 2023, the PMDA held the Biosimilar webinar for the Food and Drug Administration, Republic of the Philippines (FDA Philippines). During the webinar, PMDA staff members from the Office of Cellular and Tissue-based Products delivered lectures and case studies on biosimilars to 52 participants. Q&A sessions were also held to enhance the understanding of the topic.

The PMDA also held a pharmacovigilance webinar for the FDA Philippines on December 15, 2023. During the webinar, PMDA staff members from the Office of Pharmacovigilance I, Office of Pharmacovigilance II, and Office of International Programs delivered lectures on pharmacovigilance to 50 participants. Q&A sessions were also held to enhance the understanding of the topic.

The PMDA continuously makes efforts to strengthen collaboration with the FDA Philippines through training offered by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC).

See attached program (Biosimilar)
See attached program (PV)